Department of Medicine, Faculty of Medicine, Nile Valley University, Atabara, Sudan.
Department of Clinical Pharmacy, Faculty of Pharmacy, Omdurman Islamic University, Khartoum, Sudan.
Diabetes Metab Syndr. 2023 Mar;17(3):102743. doi: 10.1016/j.dsx.2023.102743. Epub 2023 Mar 12.
Ramadan is a holy month for Muslims. The aim of this study was to assess risk associated with Ramadan fasting among Sudanese individuals with diabetes (high, moderate, and low risk) according to International Diabetes Federation in collaboration with Diabetes and Ramadan International alliance (IDF-DAR) Practical Guidelines 2021 risk score.
This was a cross-sectional hospital-based study recruited 300 individuals with diabetes (79% have type 2 diabetes) from diabetes centers in Atbara city, the River Nile state, Sudan.
The risk score was distributed as low risk (13.7%), Moderate risk (24%), and High risk (62.3%). T-test showed a significant difference in mean risk score by gender, duration and type of diabetes (p values = 0.004, 0.000, & 0.000, respectively). One-way ANOVA revealed a statistically significant difference in the risk score by age groups (p = 0.000). Logistic regression revealed that the odds of being in the 41-60 years age group had lower probability to be categorized in the moderate risk group of fasting rather than low risk by 4.3 times than being in the age more than 60 years. (p = 0.008), the odds of being in the age group 41-60 years lower probability to be categorized in the high risk of fasting rather than low risk by 8 times than being in the age more than 60 years. (p = 0.000).
The majority of patients in this study have a high risk for Ramadan fasting. IDF-DAR risk score is of great significance in assessing individuals with diabetes for Ramadan fasting.
斋月是穆斯林的神圣月份。本研究的目的是根据国际糖尿病联合会与糖尿病与斋月国际联盟(IDF-DAR)2021 年实践指南合作制定的风险评分,评估苏丹高、中、低风险糖尿病患者(IDF-DAR)进行斋戒的相关风险。
这是一项横断面医院为基础的研究,在苏丹尼罗河州阿特巴拉市的糖尿病中心招募了 300 名糖尿病患者(79%患有 2 型糖尿病)。
风险评分分布为低风险(13.7%)、中风险(24%)和高风险(62.3%)。T 检验显示,性别、病程和糖尿病类型的平均风险评分存在显著差异(p 值分别为 0.004、0.000 和 0.000)。单因素方差分析显示,年龄组之间的风险评分存在统计学差异(p=0.000)。Logistic 回归显示,41-60 岁年龄组的患者,其归类为中等风险禁食组的可能性比 60 岁以上年龄组低 4.3 倍。(p=0.008),41-60 岁年龄组的患者,其归类为高风险禁食组的可能性比 60 岁以上年龄组低 8 倍。(p=0.000)。
本研究中的大多数患者进行斋月斋戒的风险较高。IDF-DAR 风险评分在评估糖尿病患者进行斋月斋戒方面具有重要意义。